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A B S T R A C T
Ionising radiation can transfer sufﬁcient energy to ionise molecules, and this can lead to chemical changes,
including DNA damage in cells. Key evidence for the carcinogenicity of ionising radiation comes from:
follow-up studies of the survivors of the atomic bombings in Japan; other epidemiological studies of groups
that have been exposed to radiation from medical, occupational or environmental sources; experimental
animal studies; and studies of cellular responses to radiation. Considering exposure to environmental
ionising radiation, inhalation of naturally occurring radon is the major source of radiation in the population
– in doses orders of magnitude higher than those from nuclear power production or nuclear fallout. Indoor
exposure to radon and its decay products is an important cause of lung cancer; radon may cause
approximately one in ten lung cancers in Europe. Exposures to radon in buildings can be reduced via a three-
step process of identifying those with potentially elevated radon levels, measuring radon levels, and
reducing exposure by installation of remediation systems. In the 4th Edition of the European Code against
Cancer it is therefore recommended to: ‘‘Find out if you are exposed to radiation from naturally high radon
levels in your home. Take action to reduce high radon levels’’. Non-ionising types of radiation (those with
insufﬁcient energy to ionise molecules) – including extremely low-frequency electric and magnetic ﬁelds as
well as radiofrequency electromagnetic ﬁelds – are not an established cause of cancer and are therefore not
addressed in the recommendations to reduce cancer risk.
 2015 International Agency for Research on Cancer; Licensee ELSEVIER Ltd https://creativecommon-
s.org/licenses/by-nc-nd/3.0/igo/
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1.1. Introduction
Natural and man-made sources generate radiant energy in the
form of electromagnetic waves; these are characterised by their
wavelength, frequency and photon energy. The electromagnetic
spectrum includes static (non-alternating) electric and magnetic
ﬁelds, low-frequency electric and magnetic ﬁelds (low energy, long
wavelengths), intermediate and radiofrequency (RF) electromag-
netic ﬁelds (EMF), microwaves, optical radiation (infrared, visible
light, ultraviolet radiation) and gamma- and X-rays (ionising
radiation with high energy and very short wavelengths) (Fig. 1). In
addition to electromagnetic waves, ionising radiations include
particulate sources: notably neutrons, electrons (beta particles)inst Cancer 4th Edition: Ionising and non-ionising radiation and
ep.2015.03.016
d https://creativecommons.org/licenses/by-nc-nd/3.0/igo/
Box 1. European Code Against Cancer.
EUROPEAN CODE AGAINST CANCER
12 ways to reduce your cancer risk
1. Do not smoke. Do not use any form of tobacco.
2. Make your home smoke-free. Support smoke-free policies
in your workplace.
3. Take action to be a healthy body weight.
4. Be physically active in everyday life. Limit the time you
spend sitting.
5. Have a healthy diet:
 eat plenty of whole grains, pulses, vegetables and fruits;
 limit high-calorie foods (foods high in sugar or fat) and avoid
sugary drinks;
 avoid processed meat; limit red meat and foods high in salt.
6. If you drink alcohol of any type, limit your intake. Not
drinking alcohol is better for cancer prevention.
7. Avoid too much sun, especially for children. Use sun pro-
tection. Do not use sunbeds.
8. In the workplace, protect yourself against cancer-causing
substances by following health and safety instructions.
9. Find out if you are exposed to radiation from naturally high
radon levels in your home. Take action to reduce high radon
levels.
10. For women:
 breastfeeding reduces the mother’s cancer risk; if you can,
breastfeed your baby;
 hormone replacement therapy (HRT) increases the risk of
certain cancers. Limit use of HRT.
11. Ensure your children take part in vaccination programmes
for:
 hepatitis B (for newborns);
 human papillomavirus (HPV) (for girls).
12. Take part in organised cancer screening programmes for:
 bowel cancer (men and women);
 breast cancer (women);
 cervical cancer (women).
The European Code Against Cancer focuses on actions that
individual citizens can take to help prevent cancer. Successful
cancer prevention requires these individual actions to be
supported by governmental policies and actions.
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netic waves and neutrons can penetrate the body from external
sources, charged particles – including alpha and beta particles – have
limited ability to penetrate body tissues, and risks are generally
associated with their entry into the body by inhalation or ingestion.
Ionising radiation and ultraviolet radiation (UVR) are known to
cause cancer [1,2], but the evidence regarding non-ionising
radiation is equivocal [3,4]; while there is a mechanistic
understanding of the cellular effects of ionising radiation and
UVR, plausible mechanisms have not been established for the
effects of non-ionising radiation. The cancer risk from ionising
radiation, in particular radon, justiﬁes the recommendation of the
4th edition of the European Code against Cancer (Box 1). Ionising
radiation from medical diagnostics and treatment is discussed
elsewhere, together with other medical exposures [5]. UVR, also
subject to a recommendation, is discussed elsewhere [6]. In this
paper, we also cover non-ionising radiation (the EMF part), for
which the scientiﬁc evidence has been evaluated and shows that it
is not an established cause of cancer, and is therefore not addressed
by a recommendation of the Code.
1.2. Exposure to sources of ionising radiation
Radioactive substances are a source of ionising radiation. An
important characteristic of these radioactive materials is the rate atPlease cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.canwhich they decay, either into another radioactive nuclide or into a
stable (i.e. non-radioactive) nuclide. The decay rate is normally
expressed in terms of the nuclide’s half-life, namely, the time taken
for the radioactivity of any given amount of the particular
radionuclide to decay to half of its initial value. The amount of a
radioactive substance is generally measured in terms of its activity
or radioactive decay rate, with units of becquerel (Bq); 1 Bq equals
one nuclear decay event per second. Each radionuclide, depending
on its degree of nuclear instability, has a characteristic radioactive
half-life, and nuclear decay is accompanied by a speciﬁc yield of
energy depending on the radiations emitted (e.g. alpha, beta).
Many radioactive materials exist naturally. Primordial radioac-
tive elements include uranium-238 that has a radioactive half-life
of around 4.5  109 years leading to the radioactive decay chain
that includes radon-222 (which together with its progeny/
daughter isotopes/decay products is referred to as ‘radon’ below).
Some human activities create radioactive materials either deliber-
ately or as a by-product. Nuclear ﬁssion of uranium-235 in nuclear
reactors is a source of man-made radionuclides. Some devices,
such as x-ray sets used in medicine and in industrial inspection,
generate and emit ionising radiation without the presence of
radioactive material.
Radioactive materials external to the body can result in
radiation exposure and cancer risk if the emitted radiations can
penetrate to body organs and tissues, as is the case for gamma rays,
X-rays and neutrons [7]. Entry of radioactive materials into the
body, mainly by inhalation or ingestion, can lead to their
deposition and retention in body organs and tissues, resulting in
continued irradiation. For so-called non-penetrating radiations –
including beta and alpha particles – risk to health is largely the
result of such internal exposures. The extent to which speciﬁc
organs and tissues are exposed from a radionuclide within the
body depends on various factors: the mode of entry into the body;
the physical and chemical properties of the incorporated radio-
nuclides; the radiations emitted; the radioactive half-lives of the
incorporated radionuclide and its decay products; and the
distribution within and elimination from the body [7]. A short-
lived, insoluble, alpha-emitting radionuclide that is ingested
would irradiate the gut more than other tissues. In contrast, a
long-lived, highly soluble, gamma-emitting radionuclide that is
inhaled may be distributed around and irradiate most of the body’s
tissues before being excreted.
For all types of ionising radiation exposure, radiation dose is
deﬁned as the energy deposited as a result of ionisations and
excitations per unit mass of material. This quantity is referred to as
the absorbed dose and has the unit of gray (Gy), where 1 Gy equals
1 J/kg. At sufﬁciently high doses, the predominant effect is cell
killing, leading to gross organ damage and potentially to death. If
an individual escapes death (from exposure-related cell killing)
and at all lower doses, the predominant effect of concern is an
increased probability of cancer (see below). For radiological
protection purposes, the International Commission on Radiological
Protection (ICRP) has deﬁned the quantity, the effective dose (unit
of Sievert, Sv), as a risk-adjusted dosimetric quantity for use in the
control of radiation exposures. The effective dose is calculated
from absorbed dose, adjustments being made for differences
between radiation types in their ability to cause cancer (per Gy)
and differences between organs and tissues in their sensitivity to
the induction of cancer. For example, alpha particles are more
effective in causing cancer per Gy of radiation than gamma rays,
and this is recognised for protection purposes using a radiation
weighting factor of 20. The greater sensitivity of the colon than the
liver to radiation-induced cancer (as suggested, for instance, by the
higher risk of colon cancer than liver cancer in the atomic bomb
survivors in Japan, shown in Fig. 2), for example, is recognised in
tissue weighting factors of 0.12 and 0.04, respectively [7]. It shouldinst Cancer 4th Edition: Ionising and non-ionising radiation and
ep.2015.03.016
Fig. 1. Electromagnetic spectrum. The electromagnetic spectrum extends from below the low frequencies used for modern radio communication to gamma radiation at the
shortest wavelength and highest frequency. Reproduced from the European Commission, Research Directorate-General, European Communities (2005). Health and
Electromagnetic Fields: EU-funded research into the impact of electromagnetic ﬁelds and mobile telephones on health.  European Communities, 2005.
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applied for protection purposes and they do not fully reﬂect our
scientiﬁc understanding and would not be used in the calculation
of risks to speciﬁc population groups or individuals. Thus, for
example, radiation effectiveness is known to be dependent on
cancer type and organ/tissue sensitivity and is age- and sex-
dependent [8,9].
Estimates are made, nationally and internationally, of the
sources and distribution of radiation exposures of populations.
According to the latest periodic review of radiation exposures by
the United Nations Scientiﬁc Committee on the Effects of Atomic
Radiation (UNSCEAR) [10], reference individuals receive an
average of about 3 mSv effective dose annually but, within a
population, there may be a wide range of individual exposures
from less than 1 to more than several tens of mSv. For any
individual, the absolute and relative contributions of different
sources of radiation exposure will depend on many factors,
including their home location (e.g. radon and cosmic ray exposure),
exposure as patients during medical diagnostic procedures (e.g. X-
rays, computerised tomography (CT) scans) or radiotherapy, their
job (workplace exposure), and dietary choices (ingestion ofFig. 2. Estimates of solid cancer mortality risk for different organs from studies of
the survivors of the atomic bombings in Japan. The ﬁgure shows the excess relative
risk per unit dose (Sv1) of various cancer types from radiation exposure among the
survivors of the atomic bombings in Japan. Reproduced with permission from
United Nations/UNSCEAR [18]. aWhile the absorbed dose is expressed in gray (Gy),
because radiations differ in their ability per Gy to cause cancer, a radiation-
weighted quantity, equivalent dose, is used, expressed in Sievert (Sv) (see Section
1.2). The horizontal bars represent 90% conﬁdence intervals.
Please cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.canradionuclides). However, everybody is exposed to ionising
radiation to some extent owing to the abundance of natural
sources. Fig. 3 shows the relative contributions from different
sources to the estimated average annual exposure estimated for
the global population. Much of the radiation exposure of a typical
individual comes from natural radiation sources, including internal
exposure from inhaling radon decay products when indoors,
external exposure from gamma-emitting radionuclides in rocks,
soil and building materials, and internal exposure from ingestion of
natural radionuclides in food and drink [10].
The predominant source of man-made radiation exposure is the
use of radiation for medical diagnostic and therapeutic purposes
[10]; medical exposure to ionising radiation will be discussed in a
separate article [5]. Other anthropogenic sources include: external
and internal exposure of the public to radionuclides released into
the environment from nuclear power plants, both low-level
releases during normal operations and exposures resulting from
past accidents (such as those at Chernobyl and Fukushima);
exposures to fallout from nuclear weapons testing; and occupa-
tional radiation exposures of workers including those in the health
care, nuclear industry, airline pilots and some miners [10]. Togeth-
er, these non-medical man-made sources make only a minor
contribution to the overall population exposure. For most people,
radon is the largest individual component of exposure to ionising
radiation.Fig. 3. Components of worldwide annual average individual radiation dose. The pie
chart shows the annual average dose to the representative individual from the
different radiation sources. Inhalation of radon (=Radon); ingestion of radionuclides
in food and drink (=food/drink water); external irradiation from cosmic rays
(=Cosmic); external irradiation from radionuclides in building materials and soil
(=Buildings/soil); external and internal irradiation from medical diagnosis
(=Medical diagnosis); external radiation and ingestion/inhalation from other
man-made sources (=Other man-made). Reproduced from [10].
inst Cancer 4th Edition: Ionising and non-ionising radiation and
ep.2015.03.016
Fig. 4. Map of radon in Europe. Arithmetic means over 10 km  10 km cells of long-term radon concentration in ground-ﬂoor rooms. Data available up until May 2014
included. Reproduced with permission of Oxford University Press [52].
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Radon is an inert gas with several radioactive isotopes. Radon-
222 is formed by the radioactive decay of uranium-238 that is
present in small quantities in all soils and rocks. Other radon
isotopes are generally less important for health than radon-222
because their short half-lives limit their presence in inhaled air.
Radon-222 has a 3.8-day half-life, sufﬁcient to allow time for
accumulation above ground in homes and other buildings. In
outdoor air, it is generally diluted to negligible concentrations [11].
Buildings, including homes, have slightly reduced air pressure
relative to outdoor air, due to indoor heating and air movement.
Soil air, containing radon, is drawn from the ground into a building
through openings and minor defects in the foundations such as in
seams and utility entry points. It may be retained within the
building unless removed by ventilation, and this can lead to
elevated concentrations in indoor air which can reach hundreds or
thousands of becquerels per cubic metre (Bq m–3) [12]. As an inert
gas, inhaled radon is mostly exhaled. However, radon has a number
of radioactive decay products with very short half-lives which
include alpha-particle-emitting isotopes of polonium (218 and
214) which are deposited within the lungs and are a recognised
cause of lung cancer.
Radon is present in most rocks and soil. The concentrations in
homes and workplaces depend on a number of factors, including:
the abundance of radium-226 (a long-lived intermediate decay
product of uranium-238) in the ground; the permeability of the
soil; the openings in the foundations of the building through which
radon can enter a building from the ground; and the extent to
which a particular building retains radon. These variations can
result in a wide range of indoor radon concentrations even in aPlease cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.cansmall geographical area. Two apparently identical adjacent homes
can have very different indoor radon levels. UNSCEAR [13]
estimated a worldwide population-weighted geometric mean
indoor level of 30 Bq m3. Fig. 4 shows the geographical
distribution means of long-term radon concentrations in ground
ﬂoors across Europe. A small proportion of radon exposure arises
from its presence in and emanation from building materials and
water supplies.
1.4. Exposure to non-ionising radiation
Exposure to static and to extremely low-frequency electric and
magnetic ﬁelds is ubiquitous due to natural phenomena and power
transmission and the use of electrical appliances. Examples of
natural sources of exposure include the geomagnetic ﬁeld of the
earth and, as extreme phenomena, thunder and lightning. Normal
residential background exposure to extremely low-frequency
magnetic ﬁelds is usually below 0.1 mT (ﬂux density or magnetic
ﬁeld strength) [14]. A small fraction of households located very
close to high-voltage power lines or other sources (including
indoors) can have higher exposures, but usually well below
protection limits – deﬁned by the International Commission for
Non-Ionising Radiation Protection (ICNIRP) – for the general
population [15]. Higher but short-term exposures occur in
particular jobs such as those of electricians.
For the majority of people, highest exposures to radiofrequency
electromagnetic ﬁelds occur when using mobile phones because
the source of emission is held close to the head. Much lower levels
of exposure arise from high-power TV and radio transmitters, but
the electric ﬁeld strength may exceed 1 V/m even at points several
kilometres from transmitters [16]. Exposures from smallerinst Cancer 4th Edition: Ionising and non-ionising radiation and
ep.2015.03.016
Fig. 5. Relative risk of lung cancer in relation to long-term residential radon
concentrations in the European pooling study (with 95% conﬁdence intervals).
Relative risks and 95% conﬁdence intervals are shown for categorical analyses and
also the best-ﬁtting straight line. Risks are relative to that at 0 Bq m3. From Radon
and Public Health [23].  Crown copyright. Reproduced with permission of Public
Health England.
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normally even lower except in their immediate vicinity [17]. The
number of sources continues to increase with further utilisation of
the whole electromagnetic frequency spectrum and further
development of new wireless technologies.
2. Cancer risk from ionising radiation
2.1. Ionising radiation and cancer
Large numbers of studies have investigated the effects of
ionising radiation exposure as a cause of haematological malig-
nancies and solid cancers. Ionising radiation has been classiﬁed by
the International Agency for Research on Cancer (IARC) as an
established or class I carcinogen [1]. Key evidence for the
carcinogenicity of ionising radiation has been reviewed by IARC,
the United Nations Scientiﬁc Committee on the Effects of Atomic
Radiation [11], and the International Commission on Radiological
Protection [7]; it includes: the Life Span Study of survivors of the
atomic bombings in Japan exposed at the end of the second world
war; other epidemiological studies of groups that have been
exposed to radiation from medical, occupational or environmental
sources; experimental animal studies; and studies of cellular
responses to radiation including DNA damage.
Fig. 2 illustrates some of the evidence for radiation-associated
cancer and the magnitude of risk to different tissues. It shows the
excess relative risk per dose unit (Sv) of various cancer types
among the survivors of the atomic bombings in Japan.
In its 2011 summary report of low-dose radiation effects on
health [18], UNSCEAR stated that ‘‘. . . the energy deposited in the
cell after irradiation can damage all subcellular components. The
main subcellular targets for radiation-associated cellular change
are the DNA molecules residing in the chromosomes. . . The cell
may survive but with DNA mutations that affect cellular behaviour.
A small fraction of such mutations can contribute to cancer
development. . .. Complex DNA damage is difﬁcult to repair
correctly, and even at low doses of radiation it is likely that there
is a very small but non-zero chance of the production of DNA
mutations that increase the risk of cancer developing. Thus, the
current balance of available evidence tends to favour a non-
threshold response for the mutational component of radiation-
associated cancer induction at low doses and dose-rates.’’
ICRP judges [7] that the weight of evidence supports the view
that it is ‘‘scientiﬁcally plausible to assume that the incidence of
cancer. . . will rise in direct proportion to an increase in the
equivalent dose in the relevant organs and tissues.’’
These conclusions from UNSCEAR and ICRP embody what is
generally referred to as the linear, no-threshold (LNT) dose–
response model. It implies that there is no level at which the risk is
zero, but any additional exposure to ionising radiation increases
the lifetime cancer risk, adding to the underlying cancer risk from
other causes. The ICRP risk factor [7] for cancer induction in a
mixed age population is 5.5% per Sv of effective dose delivered at
low dose and dose rate.
2.2. Radon and cancer
There is substantial epidemiological evidence that indoor
exposure to radon and its decay products is an important cause
of lung cancer, second only to tobacco smoking. Several large-scale
epidemiological studies – including pooled analyses of uranium
miners and populations exposed to elevated radon levels at home
[19–22] – have demonstrated that long-term exposure to radon
increases the risk of lung cancer. Pooled case–control studies have
also shown that the excess relative risk of lung cancer is
proportional to long-term radon exposure levels for smokers,Please cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.cannon-smokers and ex-smokers, as illustrated in Fig. 5 [20,23]. The
UK independent Advisory Group on Ionising Radiation (AGIR)
reported a 16% excess relative risk from long-term (30 years)
exposure to radon in air at a concentration of 100 Bq m3, with a
95% conﬁdence interval of 5–31% [23]. The results provide direct
evidence of increased lung cancer risk at radon levels below
200 Bq m3. The greatest absolute lung cancer risks from radon
exposure were to continuing smokers, primarily because smoking
induces a much higher baseline lung cancer risk, and radon acts
multiplicatively with other lung cancer risks. In other words, the
vast majority of radon-induced cancers develop among smokers as
a joint effect of radon and smoking. Darby et al. [19,20] estimated
the fraction of the lung cancer burden attributable to indoor radon
in Europe to be about 9%. The World Health Organization (WHO)
[12] reported estimates ranging from 3% to 14% across some
selected populations around the world, including some from
Europe, based on a large pooling study for the UK (3.3%), Germany
(5%), France (5%), and Switzerland (8.3%).
2.3. Other relevant sources of ionising radiation and cancer
Studies of nuclear workers exposed mainly to low doses of
external radiation under relatively well controlled conditions
demonstrated a small increase in cancer mortality associated with
exposure at work [24,25]. In a study of nuclear workers from
15 countries, 1–2% of deaths from solid cancers were considered to
be possibly related to their occupational exposure [24]. Analysis of
cancer incidence in the very large cohort of workers included in the
UK National Registry for Radiation Workers showed a signiﬁcant
dose–response relationship consistent with the extrapolation of
the A-bomb risk factors to low doses [25]. Studies of cancer
incidence in plutonium workers at the Russian Mayak plant have
shown plutonium-239-related excesses of lung and liver cancers
[26,27]. Comparisons of lung cancer incidences following expo-
sures to radon progeny (uranium miners), plutonium and external
gamma rays show that risk estimates are consistent when account
is taken of the relative biological effectiveness (RBE) of alpha
particles and gamma rays [28]. The data are consistent with alpha
particle RBE values of around 10–20, although Marsh et al. [28]
noted the considerable uncertainties associated with these
estimates.inst Cancer 4th Edition: Ionising and non-ionising radiation and
ep.2015.03.016
N. McColl et al. / Cancer Epidemiology xxx (2015) xxx–xxx6
G Model
CANEP-861; No. of Pages 8Excesses of childhood leukaemia incidence in populations near
nuclear installations in the UK, Germany and other countries have
been recorded, but a number of similar studies have failed to show
any increased risks [9,29]. The radiation doses in these populations
are well below the levels that might cause any discernible excess
risk of cancer in the light of current understanding, particularly as
doses from natural sources have been shown to dominate and
exceed any contributions from radioactive discharges from nuclear
facilities. Overall there is no good evidence that any step in the
production of nuclear power under controlled conditions is related
to any cancer excess in the populations of the adjacent areas.
However, nuclear accidents such as that at the Ukrainian
Chernobyl plant can result in exposure to radiation doses resulting
in elevated cancer risks, depending on the release of radionuclides
and the location [10]. In addition, radioactive discharges from the
Mayak plant into the Techa River were sufﬁciently high in the early
years of operation to lead to increases in both haematological
malignancies and solid cancers [30,31]. The recent accident at the
Fukushima plant in Japan resulted in exposures that were an order
of magnitude or more below those experienced following the
Chernobyl reactor, and discernible increases in cancer incidence
are not expected [32,33].
2.4. Non-ionising radiation and cancer
Epidemiological studies have consistently shown a positive
association of extremely low-frequency magnetic ﬁelds with an
approximately two-fold higher childhood leukaemia risk at average
exposure levels exceeding 0.3–0.4 mT [15]. A causal relationship,
however, has not been established due to the potential for bias and
confounding in the studies and because supporting evidence from
experimental studies and mechanistic data are lacking. The
2002 IARC Monograph [3] on extremely low-frequency magnetic
ﬁelds classiﬁed them as possibly carcinogenic to humans (group 2B)
based on the ﬁndings for childhood leukaemia; the evidence for
other types of malignancy was evaluated to be inadequate. This view
was recently conﬁrmed by the European Commissions’ Scientiﬁc
Committee on Emerging and Newly Identiﬁed Health Risks
[34]. Radiofrequency electromagnetic ﬁelds (group 2B) have also
been classiﬁed by the IARC [4] as possibly carcinogenic to humans on
the basis of ﬁndings for glioma and acoustic neuroma. Case–control
studies on mobile phone use and cancer have reported increased
risks of glioma and acoustic neuroma in heavy users of mobile
phones, based on self-reported mobile phone use [35,36]. Cohort
studies have shown no associations, but had fewer data on heavy
users [37,38]. Time trends in glioma incidence based on Nordic
countries excluded any signiﬁcant increased incidence attributable
to mobile phone usage of up to 10 years [39]. With regard to
environmental exposures from transmitters – including television,
radio, and military transmissions as well as mobile phone base
stations – the evidence is inadequate due to paucity of high-quality
studies with accurate individual exposure assessment [40]. Some
large studies on childhood cancer and ﬁelds generated by high-
output TV and/or radio transmitters reported no associations
[15]. Overall, currently available information does not provide
unequivocal evidence that non-ionising radiation at low and high
frequencies is a cause of cancer.
3. Scientiﬁc justiﬁcation of the recommendation on radon
The carcinogenicity of ionising radiation is well documented
[1]. Ionising radiation can cause many types of cancer and
haematological malignancies. Some exposure to ionising radiation
is unavoidable – for instance that from cosmic radiation or
terrestrial radiation. The major source of man-made radiation is
medical exposure; the exposure is intentional and brings beneﬁtPlease cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.canthrough diagnoses or treatment. Therefore controlled and judi-
cious use of radiation in medicine is associated with risks that are
counterbalanced with beneﬁts [5]. Man-made radiation also occurs
in some occupational settings for which regulations are in place,
such as the Euratom 2014 Basic Safety Standards [41]. These
regulations provide a range of controls, including: risk assessment;
control of radiation use and procedures for radiation safety and
protection; and personal and environmental radiation monitoring
where appropriate. The recommendation of the Code to follow
health and safety advice to reduce occupational exposure deﬁned
elsewhere also applies to ionising radiation [42]. Other man-made
exposures – such as for example those related to the use of nuclear
energy under normal conditions – are sometimes of concern in the
population. Nevertheless, they generally contribute little to overall
radiation exposure (Fig. 3). This does not apply to major nuclear
accidents with major radionuclide releases.
The major source of exposure to ionising radiation, modiﬁable
by the individual, comes from naturally occurring radon. While
this naturally occurring exposure cannot be eliminated, it can be
substantially reduced at places where people spend much of their
time, namely in their own homes or at their workplaces. Radon is
estimated to account for about one in ten lung cancers in Europe
[18], therefore causing a major cancer burden. The respective
recommendation is: ‘‘Find out if you are exposed to radiation from
naturally high radon levels in your home. Take action to reduce
high radon levels’’.
3.1. Individual action for protection against radon
3.1.1. Variation in radon exposure
Radon concentrations in homes and other buildings vary
substantially, as discussed in Section 1.3. The radon exposures
of building occupants depend primarily on the proportion of time
they spend in the building. Over the course of a year, most people
spend a majority of their time in their home, mostly in living rooms
and bedrooms. Homes are therefore the primary source of indoor
radon exposure, with workplaces presenting the second most
important source of exposure with radon concentrations typically
similar to or slightly lower than those in homes (although high
concentrations can occur in particular workplaces, especially
underground).
It is not generally possible to accurately predict the indoor radon
concentration in a speciﬁc building, and measurements are required.
However, a number of countries (see for example [43–45]) have used
radon or related measurements or geological information to identify
radon-prone areas where high radon levels are more common. Maps
indicating radon-prone areas are used in some countries to provide
guidance on whether radon measurements should be made in
existing properties to inform remediation decisions (Fig. 4).
3.1.2. Measuring radon in the home
Indoor radon levels vary considerably over short periods (hours
and days) [46], and seasonally through the year [47]. Within any
home, there is often a variation in concentration between rooms.
Measurements of radon are generally intended to represent the
long-term average concentration in the home. For this reason,
radon measurements in homes are often made using two detectors
placed in regularly occupied rooms, including a bedroom, for
several weeks. Measurements made during different times of the
year can be adjusted to reﬂect seasonal variations [47]. Shorter
duration measurements may be made but the results are less
accurate and have greater uncertainties.
3.1.3. Managing individual risks from radon exposure
The distribution of residential radon exposures in a population
reﬂects the geometric mean of indoor radon concentrations with ainst Cancer 4th Edition: Ionising and non-ionising radiation and
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exposure to radon will therefore arise from the many homes that
have relatively modest indoor radon concentrations [12]. The
modest cost of including radon preventative measures in new
buildings is sufﬁciently low as to support preventive measures in
new buildings [12]. Maps of radon-prone areas can be used to
support policies on radon preventive measures in new buildings,
such as requiring the installation of impermeable membranes at
the building foundation level.
Most radon strategies focus on identifying and managing the
homes with the highest radon concentrations. International
guidance is available from the ICRP [48] and the WHO [12] on
radon concentration levels (termed ‘‘reference levels’’ by the ICRP),
above which action should be taken to reduce indoor radon
concentrations, and below which concentrations should be
reduced as far as is reasonably achievable. The WHO and ICRP
have advised that relevant national authorities should establish
radon reference levels for homes in the range 100–300 Bq m3. The
ICRP system of radiological protection [7] advises that reference
levels of radiation dose for ‘‘existing exposure situations’’ such as
radon in buildings, should be implemented using dose criteria in
the range 1–20 mSv y1. ICRP has advised [48] that a derived
reference level of 300 Bq m3 for homes is consistent with this
aspect of its system of radiological protection.
A European Union directive, setting out requirements for
protection against ionising radiation [41], has established criteria
for managing indoor radon, setting an upper limit of 300 Bq m3 on
national reference levels unless there are extenuating circum-
stances. Means to manage high individual radon exposures in the
home include provision of resources and funding for radon risk
assessments, measurements or remediation [49] and provision of
information to the householder [50]. The European Code Against
Cancer recommendation concerning radon in the home expects the
householder to take responsibility for managing the radon risk in
their home. Such an approach complements programmes to
encourage or support householders in radon management and
complements responsibilities that landlords have to provide safe
housing for their tenants.
3.1.4. Reducing high indoor radon levels
Practical methods are available for reducing high radon levels in
existing properties [12], usually at modest cost. These generally
work by either reducing the radon concentration at the point
where it enters the building from the ground, or reducing the air
pressure differential between the building and the ground that is
the driving force for soil air and radon to enter the home.
Experience to date [51] suggests that the most effective solutions
are based on low-power electrical air pumps, typically consuming
a few tens of watts that work continuously and can achieve
reductions in radon concentration to a tenth of the original level.
The most commonly used remediation systems include: (1) a
‘‘radon sump’’ – a small, engineered, partially depressurised void
beneath the building from which soil air and radon are continually
pumped through pipes and expelled to atmosphere; and (2)
positive pressure ventilation, in which air is pumped into a central
area of the home to reduce the pressure differential between
indoor air and soil air. Some passive (non-powered) methods are
available but these generally result in smaller concentration
reductions and are therefore not suitable for reducing the highest
radon levels [52,53].
4. Conclusions
Ionising radiation has been shown to be carcinogenic and
everyone is exposed to a range of natural and man-made sources.
Radon is the single biggest source of ionising radiation exposure forPlease cite this article in press as: McColl N, et al. European Code aga
cancer. Cancer Epidemiology (2015), http://dx.doi.org/10.1016/j.canmost people, with most exposure occurring in the home. Radon is
the second leading cause of lung cancer after smoking, with long-
term exposure shown to result in excess lung cancers. Radon levels
vary between regions and even between neighbouring buildings. A
suitable radon measurement is needed to determine the radon
level in any speciﬁc property. National agencies can prepare maps
indicating the geographical variation of indoor radon. In areas
where high indoor radon levels are more common, radon
measurements should be made comprehensively, particularly in
homes. International organisations, including the WHO, have
advised that countries should establish reference levels of indoor
radon in the range 100–300 Bq m3, above which steps should be
taken to reduce concentrations. Minor building modiﬁcations can
be made to reduce high indoor radon levels. For new buildings,
techniques should be employed to minimise radon levels, as this
can be achieved easily and also reduces other hazards such as
moisture damage.
Householders should:
 take ownership of the radon issue for their home;
 use the available national information to decide whether to test
their home for radon;
 test their home for radon where this is advised, reduce high
radon levels in the home.
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